METASTATIC PAPILLARY RENAL CELL CARCINOMA
Clinical trials for METASTATIC PAPILLARY RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PAPILLARY RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PAPILLARY RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mushroom compound targets kidney cancer in dialysis patients
Disease control Recruiting nowThis early-stage trial is testing a drug called orellanine, derived from a mushroom, in 75 people with advanced kidney cancer who are also on dialysis. The drug is given intravenously to see if it is safe and can shrink tumors. All participants have end-stage kidney disease and h…
Matched conditions: METASTATIC PAPILLARY RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Oncorena AB • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for rare cancers: Triple-Drug attack shows promise
Disease control Recruiting nowThis phase II trial is testing whether a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—can shrink or slow the growth of rare genitourinary cancers that have spread. About 314 adults with these uncommon tumors will receive the drugs. The goal is to see if the …
Matched conditions: METASTATIC PAPILLARY RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC